Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy

BACKGROUND: Maternal risks of betamethasone have been rarely reported. CASE: At 36 weeks' gestation, a previously healthy 23-year-old gravida with fetal intrauterine growth restriction was admitted to the hospital for steroid administration. Twenty-six hours after the first dose of betamethason...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarumi, Mojirayo A., Hole, James W., Gherman, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815974/
https://www.ncbi.nlm.nih.gov/pubmed/31737387
http://dx.doi.org/10.1155/2019/6873057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815974/
https://www.ncbi.nlm.nih.gov/pubmed/31737387
http://dx.doi.org/10.1155/2019/6873057

Ejemplares similares